Minimizing hair loss helps patients to preserve personal identity and self-esteem and appear normal as opposed to sick. Protecting privacy and gaining the ability to choose whether to disclose a cancer diagnosis is significant to many patients. Additionally, scalp cooling patients gain a much-needed sense of control in an otherwise overwhelming experience.

As Published
Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced alopecia.
San Antonio Breast Cancer Symposium Abstract, December 2016
Cigler, T, et al.

A total of 117 patients were enrolled in the pivotal trial. 101 received scalp cooling using DigniCap and 16 were in the control group with no scalp cooling.


Women with breast cancer receiving scalp cooling using DigniCap versus control during chemotherapy: 

  • Were significantly less likely to lose ≥ 50% of their hair
  • Felt significantly more physically attractive
  • Were significantly less dissatisfied with their appearance when dressed
  • Regarded the importance of hair significantly more

“Scalp cooling is clinically proven and can be an important tool for many women in treatment for breast cancer. As a world-leader in comprehensive cancer care we are proud to be able to offer our patients across the New York metro area this FDA-cleared advancement that addresses one of the most distressing and most visible side effects of chemotherapy.” – Tessa Cigler, MD, MPH

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 877-350-2150

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

Aurora BioScience
PO Box 946
Baulkham Hills NSW 2153
+61 1300 309 994
+64 0800 533 272